Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation.
Aoki T, Kasai M, Harada Y, Matsubara E, Morishita T, Suzuki T, Tsujita M, Goto N, Katayama A, Watarai Y, Uchida K, Ito M, Saji H, Tsuzuki T, Uchida T, Ogura M. Aoki T, et al. Among authors: morishita t. Int J Hematol. 2013 Jul;98(1):129-34. doi: 10.1007/s12185-013-1355-3. Epub 2013 May 11. Int J Hematol. 2013. PMID: 23666631
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
Imoto N, Hayakawa F, Kurahashi S, Morishita T, Kojima Y, Yasuda T, Sugimoto K, Tsuzuki S, Naoe T, Kiyoi H. Imoto N, et al. Among authors: morishita t. J Biol Chem. 2016 Feb 26;291(9):4723-31. doi: 10.1074/jbc.M115.637835. Epub 2015 Dec 24. J Biol Chem. 2016. PMID: 26703467 Free PMC article.
PAX5 tyrosine phosphorylation by SYK co-operatively functions with its serine phosphorylation to cancel the PAX5-dependent repression of BLIMP1: A mechanism for antigen-triggered plasma cell differentiation.
Inagaki Y, Hayakawa F, Hirano D, Kojima Y, Morishita T, Yasuda T, Naoe T, Kiyoi H. Inagaki Y, et al. Among authors: morishita t. Biochem Biophys Res Commun. 2016 Jun 24;475(2):176-81. doi: 10.1016/j.bbrc.2016.05.067. Epub 2016 May 13. Biochem Biophys Res Commun. 2016. PMID: 27181361
Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis.
Kako S, Fujiwara S, Sato M, Kimura SI, Nakasone H, Ohashi K, Kawakita T, Maeda T, Morishita T, Suzuki R, Fukuda T, Ichinohe T, Kurata M, Atsuta Y, Kanda Y. Kako S, et al. Among authors: morishita t. Biol Blood Marrow Transplant. 2018 Oct;24(10):2139-2144. doi: 10.1016/j.bbmt.2018.04.015. Epub 2018 Apr 19. Biol Blood Marrow Transplant. 2018. PMID: 29680515 Free article. Clinical Trial.
Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M. Sato T, et al. Among authors: morishita t. Bone Marrow Transplant. 2018 Oct;53(10):1359-1363. doi: 10.1038/s41409-018-0197-2. Epub 2018 May 8. Bone Marrow Transplant. 2018. PMID: 29740179 Clinical Trial. No abstract available.
848 results